KomturKomtur_Logo.svg
Contact

Access Programs Designed for Trust, Compliance, and Continuity

Patients in need can’t wait for health systems to catch up. Komtur’s Managed Access Programs (MAPs) provide structured, compliant pathways that help bring critical therapies to patients when conventional commercial channels are not yet in place. From Compassionate Use to country-specific Early Access models, every program is designed around the therapy’s context and built with the patient at its center, delivering access that is ethical, safe, and sustainable.

Whether it’s first-in-class therapies, orphan drugs, or re-entry after market withdrawal, our MAPs bridge the gap between clinical development and real-world availability. These sponsor-driven programs deliver an integrated access solution. Komtur orchestrates the process by aligning regulatory requirements, country-specific distribution, stakeholder engagement, and education for both patients and providers.

By building trust through structure and accelerating access with care, we help patients access treatment sooner and enable sponsors to move forward with confidence.

About Managed Access Programs

Komtur’s Managed Access Programs are designed to navigate the complexities of providing therapies to patients outside of traditional commercial channels. By addressing ethical, regulatory, and logistical challenges, our MAPs help pharmaceutical and biotech companies expand access to treatments, especially for rare and advanced conditions. Each program is customized to meet the unique needs of therapies, patient populations, and healthcare systems.

  • Patient-First, Compliance-Driven

    Structured access programs built around patient safety and regulatory rigor, aligned with GxP standards and ethical principles at both global and local levels.

  • Strategic Access Enablement

    Programs are designed to support broader lifecycle goals by facilitating stakeholder engagement, building market familiarity, and generating insights for future commercialization.

  • Early Market Familiarity

    Healthcare providers, institutions, and regulatory authorities can gain experience with the therapy prior to full launch, building trust and laying the groundwork for adoption.

  • Real-World Insight and Evidence Readiness

    When appropriate, Komtur’s programs can enable structured feedback or real-world data collection to inform HTA evaluations, label refinement, or post-approval strategies.

  • End-to-End Operational Execution

    Komtur provides full-service execution, including QP oversight, Importer of Record setup, pharmacovigilance, site coordination, and reliable last-mile delivery.

  • Therapy-Aligned Program Design

    Each MAP is carefully adapted to the specific needs of the therapy, taking into account its clinical profile, risk landscape, and the realities of national healthcare systems.

  • Stakeholder Integration with Local Reach

    Program success is built on close engagement with healthcare professionals, regulators, and patient organizations to ensure credibility, uptake, and equitable access across markets.

Our Managed Access Programs Services

Why Komtur?

  • One Platform, Integrated Access

    Komtur orchestrates access across regulatory, operational, stakeholder, and medical functions to deliver Early Access, Compassionate Use, and Patient Support services in one sponsor-aligned, patient-centric solution.

  • Lifecycle Continuity from Phase II to Post-Launch

    Our models support access from first patient supply in Early or Compassionate Use through to commercialization. We enable agile launch sequencing and consistent patient continuity across stages.

  • Global Reach with Local Adaptation

    With 18 affiliates and deep regional expertise, we tailor implementation country by country. This helps ensure local realities don’t become global bottlenecks.

  • Trusted in Complex Access Environments

    Biotech and rare disease innovators rely on Komtur to bridge clinical readiness with operational access, even when data is limited or infrastructure is fragmented.

  • Beyond Access: Supporting the Full Patient Journey

    Our PSPs deliver education, coordination, and care continuity. They help patients start and stay on therapy while reinforcing outcomes and long-term treatment success.

Start your market access plan

Let’s design a Managed Access Program that delivers safely, compliantly, and with care. Partner with Komtur to turn access goals into patient realities.

“quote XYZ .”